Baxter's $4B bid for Gambro likely to win EU clearance, sources say

07/11/2013 | Reuters

Baxter International's offer to acquire Gambro for $4 billion could be cleared by the European Commission in its decision expected by July 22, according to people familiar with the issue. The news comes after Baxter vowed to divest its global continuous renal replacement therapy unit to allay competition fears.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC